The Janus face of adenosine: antiarrhythmic and proarrhythmic actions

A Jozsef Szentmiklosi, Z Galajda… - Current …, 2015 - ingentaconnect.com
Adenosine is a ubiquitous, endogenous purine involved in a variety of physiological and
pathophysiological regulatory mechanisms. Adenosine has been proposed as an …

[HTML][HTML] Unmasking adenosine: the purinergic signalling molecule critical to arrhythmia pathophysiology and management

GDK Matthews, AA Grace - Arrhythmia & Electrophysiology Review, 2019 - ncbi.nlm.nih.gov
Adenosine was identified in 1929 and immediately recognised as having a potential role in
therapy for arrhythmia because of its negative chronotropic and dromotropic effects …

Adenosine as an antiarrhythmic agent

SL Wilbur, FE Marchlinski - The American journal of cardiology, 1997 - Elsevier
Adenosine produces acute inhibition of sinus node and atrioventricular (AV) nodal function.
This profound but short lived electrophysiologic effect makes adenosine a suitable agent for …

Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects

A Pelleg, L Belardinelli - Cardiovascular research, 1993 - academic.oup.com
Introduction n their classical paper published more than six decades ago, Drury and Szent-
Gyorgyi showed for the first time I that extracellular adenosine and related compounds exert …

[HTML][HTML] Adenosine

S Singh, R McKintosh - StatPearls [Internet], 2022 - ncbi.nlm.nih.gov
Adenosine - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Adenosine in the mammalian heart: nothing to get excited about

A Pelleg, SP Kutalek - Trends in pharmacological sciences, 1997 - cell.com
Until quite recently, the cardiodepressant actions of adenosine were widely accepted. A
nucleoside that produces negative chronotropic and ionotropic effects, adenosine, has been …

[HTML][HTML] Adenosine and the cardiovascular system: the good and the bad

R Guieu, JC Deharo, B Maille, L Crotti… - Journal of clinical …, 2020 - mdpi.com
Adenosine is a nucleoside that impacts the cardiovascular system via the activation of its
membrane receptors, named A1R, A2AR, A2BR and A3R. Adenosine is released during …

Adenosine receptors and cardiovascular disease: The adenosine-1 receptor (A1) and A1 selective ligands

ES Hayes - Cardiovascular Toxicology, 2003 - Springer
Adenosine has often been cited as a universal “retaliatory metabolite” against the
destructive cellular mechanisms that are initiated during metabolic/oxidative stress. Despite …

Role of adenosine in the treatment of cardiovascular diseases: focus on hyperemia

AS Da Silva, MD Baldissera… - International …, 2019 - internationaljournalofcardiology.com
Adenosine is a well-known purine nucleoside with a wide range of cellular and molecular
functions; it is primarily generated by breakdown of adenosine 5′ triphosphate (ATP) …

CVT‐510: A Selective A1 Adenosine Receptor Agonist

JW Cheung, BB Lerman - Cardiovascular drug reviews, 2003 - Wiley Online Library
Adenosine is an endogenous nucleoside that has potent antiarrhythmic effects on
paroxysmal supraventricular tachycardia (PSVT) due to its negative dromotropic effects on …